BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 32231045)

  • 1. The ULK1/2 and AMPK Inhibitor SBI-0206965 Blocks AICAR and Insulin-Stimulated Glucose Transport.
    Knudsen JR; Madsen AB; Persson KW; Henríquez-Olguín C; Li Z; Jensen TE
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32231045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the specificity and mechanism of action of the ULK1/AMPK inhibitor SBI-0206965.
    Ahwazi D; Neopane K; Markby GR; Kopietz F; Ovens AJ; Dall M; Hassing AS; Gräsle P; Alshuweishi Y; Treebak JT; Salt IP; Göransson O; Zeqiraj E; Scott JW; Sakamoto K
    Biochem J; 2021 Aug; 478(15):2977-2997. PubMed ID: 34259310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligomeric resistin impairs insulin and AICAR-stimulated glucose uptake in mouse skeletal muscle by inhibiting GLUT4 translocation.
    Jørgensen SB; Honeyman J; Oakhill JS; Fazakerley D; Stöckli J; Kemp BE; Steinberg GR
    Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E57-66. PubMed ID: 19435854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for 5' AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport.
    Hayashi T; Hirshman MF; Kurth EJ; Winder WW; Goodyear LJ
    Diabetes; 1998 Aug; 47(8):1369-73. PubMed ID: 9703344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytes.
    Salt IP; Connell JM; Gould GW
    Diabetes; 2000 Oct; 49(10):1649-56. PubMed ID: 11016448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of AMPK is essential for AICAR-induced glucose uptake by skeletal muscle but not adipocytes.
    Sakoda H; Ogihara T; Anai M; Fujishiro M; Ono H; Onishi Y; Katagiri H; Abe M; Fukushima Y; Shojima N; Inukai K; Kikuchi M; Oka Y; Asano T
    Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1239-44. PubMed ID: 12006353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the ERK pathway and atypical protein kinase C isoforms in exercise- and aminoimidazole-4-carboxamide-1-beta-D-riboside (AICAR)-stimulated glucose transport.
    Chen HC; Bandyopadhyay G; Sajan MP; Kanoh Y; Standaert M; Farese RV; Farese RV
    J Biol Chem; 2002 Jun; 277(26):23554-62. PubMed ID: 11978788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of TBC1D1 as an insulin-, AICAR-, and contraction-stimulated signaling nexus in mouse skeletal muscle.
    Taylor EB; An D; Kramer HF; Yu H; Fujii NL; Roeckl KS; Bowles N; Hirshman MF; Xie J; Feener EP; Goodyear LJ
    J Biol Chem; 2008 Apr; 283(15):9787-96. PubMed ID: 18276596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of AICAR and exercise on insulin-stimulated glucose uptake, signaling, and GLUT-4 content in rat muscles.
    Jessen N; Pold R; Buhl ES; Jensen LS; Schmitz O; Lund S
    J Appl Physiol (1985); 2003 Apr; 94(4):1373-9. PubMed ID: 12496137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic treatment with 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside increases insulin-stimulated glucose uptake and GLUT4 translocation in rat skeletal muscles in a fiber type-specific manner.
    Buhl ES; Jessen N; Schmitz O; Pedersen SB; Pedersen O; Holman GD; Lund S
    Diabetes; 2001 Jan; 50(1):12-7. PubMed ID: 11147776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term adenosine monophosphate-activated protein kinase activator 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside treatment increases the sirtuin 1 protein expression in skeletal muscle.
    Suwa M; Nakano H; Radak Z; Kumagai S
    Metabolism; 2011 Mar; 60(3):394-403. PubMed ID: 20362304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct small molecule ADaM-site AMPK activators reveal an AMPKγ3-independent mechanism for blood glucose lowering.
    Jørgensen NO; Kjøbsted R; Larsen MR; Birk JB; Andersen NR; Albuquerque B; Schjerling P; Miller R; Carling D; Pehmøller CK; Wojtaszewski JFP
    Mol Metab; 2021 Sep; 51():101259. PubMed ID: 34033941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prior treatment with the AMPK activator AICAR induces subsequently enhanced glucose uptake in isolated skeletal muscles from 24-month-old rats.
    Oki K; Arias EB; Kanzaki M; Cartee GD
    Appl Physiol Nutr Metab; 2018 Aug; 43(8):795-805. PubMed ID: 29518344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Is Not Necessary for Prior Pharmacological Activation of AMPK to Increase Insulin Sensitivity of Mouse Skeletal Muscle.
    Jørgensen NO; Wojtaszewski JFP; Kjøbsted R
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29662023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute exposure to AICAR increases glucose transport in mouse EDL and soleus muscle.
    Balon TW; Jasman AP
    Biochem Biophys Res Commun; 2001 Apr; 282(4):1008-11. PubMed ID: 11352652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage migration inhibitory factor diminishes muscle glucose transport induced by insulin and AICAR in a muscle type-dependent manner.
    Miyatake S; Manabe Y; Inagaki A; Furuichi Y; Takagi M; Taoka M; Isobe T; Hirota K; Fujii NL
    Biochem Biophys Res Commun; 2014 Feb; 444(4):496-501. PubMed ID: 24472542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible CaMKK-dependent regulation of AMPK phosphorylation and glucose uptake at the onset of mild tetanic skeletal muscle contraction.
    Jensen TE; Rose AJ; Jørgensen SB; Brandt N; Schjerling P; Wojtaszewski JF; Richter EA
    Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1308-17. PubMed ID: 17213473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of AMPKalpha1 signaling prevents AICAR-induced inhibition of AS160/TBC1D4 phosphorylation and glucose uptake in primary rat adipocytes.
    Gaidhu MP; Perry RL; Noor F; Ceddia RB
    Mol Endocrinol; 2010 Jul; 24(7):1434-40. PubMed ID: 20501641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α2 isoform-specific activation of 5'adenosine monophosphate-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-β-D-ribonucleoside at a physiological level activates glucose transport and increases glucose transporter 4 in mouse skeletal muscle.
    Nakano M; Hamada T; Hayashi T; Yonemitsu S; Miyamoto L; Toyoda T; Tanaka S; Masuzaki H; Ebihara K; Ogawa Y; Hosoda K; Inoue G; Yoshimasa Y; Otaka A; Fushiki T; Nakao K
    Metabolism; 2006 Mar; 55(3):300-8. PubMed ID: 16483872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockout of the alpha2 but not alpha1 5'-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle.
    Jørgensen SB; Viollet B; Andreelli F; Frøsig C; Birk JB; Schjerling P; Vaulont S; Richter EA; Wojtaszewski JF
    J Biol Chem; 2004 Jan; 279(2):1070-9. PubMed ID: 14573616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.